VHL and neoplasm: Most prominently, mutations in the tumour suppressor von Hippel–Lindau (VHL), which inhibits the transcription factor hypoxia-inducible factor (HIF), occur in kidney cancers, and the resulting accumulation of HIF drives tumour growth (Kaelin Jr, 2008; Li and Kim, 2011).